Generics - Mylan

Filter

Current filters:

Mylan

Popular Filters

1 to 25 of 30 results

Mylan to acquire certain women’s health businesses from Famy Care

Mylan to acquire certain women’s health businesses from Famy Care

02-02-2015

US generics drugmaker Mylan has signed a definitive agreement to acquire certain female health care businesses…

GenericsIndiaMergers & AcquisitionsMylanWomen's Health

European Commission clears Mylan acquisition of Abbott's European generics business

European Commission clears Mylan acquisition of Abbott's European generics business

29-01-2015

The European Commission has cleared the proposed acquisition of Abbott Laboratories’ non-US developed…

Abbott LaboratoriesEuropeGenericsMergers & AcquisitionsMylan

Germany latest country to suspend generics following GVK Biosciences concerns

Germany latest country to suspend generics following GVK Biosciences concerns

11-12-2014

The German regulator BfArM has suspended drugs including some produced by Dr Reddy’s, Mylan and Stada…

ClopidogrelDr Reddy's LaboratoriesEsomeprazole MagnesiumGenericsGermanyMylanRegulationSTADA Arzneimittel

Teva, Actavis and Mylan launch generic Celebrex capsules in USA

Teva, Actavis and Mylan launch generic Celebrex capsules in USA

10-12-2014

Israel-based generics giant Teva Pharmaceutical Industries said today that it has launched the first…

ActavisAnti-Arthritics/RheumaticsCelebrexGenericsMarkets & MarketingMylanPfizerTeva Pharmaceutcal IndustriesUSA

FDA grants tentative approval to Mylan's two dosages of abacavir/lamivudine tablets for pediatric HIV

FDA grants tentative approval to Mylan's two dosages of abacavir/lamivudine tablets for pediatric HIV

05-12-2014

The US Food and Drug Administration has granted tentative approval for New Drug Applications by US generic…

Abacavir Sulfate and Lamivudine TabletsAnti-viralsGenericsMylanRegulationUSA

Global oncology biosimilars market 2014-2018

28-11-2014

The global oncology biosimilars market is expected to expand at a compound annual growth rate (CAGR)…

BioconBiosimilarsCellTrionDr Reddy's LaboratoriesGenericsGlobalHospiraMarkets & MarketingMylanSandoz

Mylan confirms first-to-file patent challenge relating to Brevibloc

25-11-2014

US generic drugmaker Mylan today confirmed that it and several subsidiaries have been sued by US drugmaker…

Baxter InternationalBreviblocCardio-vascularGenericsLegalMylanPatentsRegulationUSA

Mylan third-qtr beats expectations

Mylan third-qtr beats expectations

31-10-2014

US generics drugmaker Mylan reported third-quarter 2014 financial results that beat analysts’ consensus…

FinancialGenericsMylan

Mylan debuts generic Viramune XR in USA

Mylan debuts generic Viramune XR in USA

31-10-2014

US generic drugmaker Mylan said yesterday that it has launched its nevirapine extended-release tablets,…

Anti-viralsBoehringer IngelheimGenericsMarkets & MarketingMylanUSAViramune

Favorable court ruling for TMC’s Angiomax patent litigation

28-10-2014

US drugmaker The Medicines Company says that the US District Court for the Northern District of Illinois…

AngiomaxCardio-vascularGenericsMylanThe Medicines CompanyUSA

Pfizer prevails in Sutent patent dispute

Pfizer prevails in Sutent patent dispute

23-10-2014

The US District Court for the District of Delaware has upheld US pharma giant Pfizer’s basic patent…

GenericsLegalMylanOncologyPatentsPfizerSutentUSA

Mylan debuts generic of ViiV’s Combivir in USA

Mylan debuts generic of ViiV’s Combivir in USA

06-10-2014

US generic drugmaker Mylan has launched of its Lamivudine and Zidovudine Tablets USP, 15mg/300mg, which…

Anti-viralsCombivirGenericsGlaxoSmithKlineMarkets & MarketingMylanUSAViiV Healthcare

Mylan starts Ph III trials for generics of Advair Diskus and insulin analog to Lantus

16-09-2014

US generic drugs major Mylan says it is initiating Phase III clinical trials for its generic version…

Advair DiskusDiabetesGenericsGlaxoSmithKlineLantusMylanResearchRespiratory and PulmonarySanofi

Mylan to acquire US rights to Arixtra Injection from Aspen

Mylan to acquire US rights to Arixtra Injection from Aspen

10-09-2014

US generic drugs major Mylan has entered into an agreement to acquire the US commercialization, marketing…

ArixtraAspen PharmacareCardio-vascularGenericsGlaxoSmithKlineMergers & AcquisitionsMylanUSA

Mylan launches first generic Klor-Con extended-release tablets

Mylan launches first generic Klor-Con extended-release tablets

22-08-2014

US generic drugs major Mylan said today that it has launched potassium chloride extended-release tablets…

GenericsKlor-ConMarkets & MarketingMetabolicsMylanUpsher-SmithUSA

Mylan’s 2nd-qtr earnings plunge on higher costs and product approval delays

Mylan’s 2nd-qtr earnings plunge on higher costs and product approval delays

07-08-2014

US generics major Mylan has reported that profits dropped nearly 30% in the second quarter of 2014, despite…

Business FinanceChief executiveFinancialFinancial ratiosFundamental analysisGenericsHeather BreschMylanUSA

Mylan wins motion to enjoin GSK from providing paroxetine CR to Apotex

Mylan wins motion to enjoin GSK from providing paroxetine CR to Apotex

17-07-2014

US generics drug major Mylan says that the US District Court for the District of New Jersey granted its…

ApotexGenericsGlaxoSmithKlineLegalMylanNeurologicalparoxetinePaxil-CRUSA

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

14-07-2014

Following a weekend of rumors and speculation, USA-based generics major Mylan and health care firm Abbott…

Abbott LaboratoriesAustraliaCanadaEuropeFinancialGenericsJapanMergers & AcquisitionsMylanNew Zealand

Mylan launches generic Micardis in USA

Mylan launches generic Micardis in USA

08-07-2014

US generic drugmaker Mylan has launched Telmisartan Tablets USP, 20mg, 40mg and 80mg, the generic version…

Boehringer IngelheimCardio-vascularGenericsMarkets & MarketingMicardisMylanRegulationTelmisartanUSA

FTC amicus brief: Improper use of restricted drug distribution programs may impede generic competition

FTC amicus brief: Improper use of restricted drug distribution programs may impede generic competition

20-06-2014

The US Federal Trade Commission has filed an amicus brief in the New Jersey US District Court explaining…

CelgeneGenericsLegalMylanPharmaceuticalRegulationUSA

Mylan launches generic Paraplatin Injection in USA

Mylan launches generic Paraplatin Injection in USA

09-06-2014

US generics major Mylan has launched carboplatin injection, 50mg/5ml, in multi-dose vials, which is the…

Bristol-Myers SquibbGenericsMarkets & MarketingMylanOncologyParaplatinRegulationUSA

1 to 25 of 30 results

COMPANY SPOTLIGHT

Menarini

Back to top